» Articles » PMID: 17573516

Viral Etiology of Acute Exacerbations of COPD in Hong Kong

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2007 Jun 19
PMID 17573516
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Viral respiratory infections may precipitate acute exacerbations of COPD (AECOPD). However, little is known about viral etiology related to AECOPD in Asia. We aimed to study the viral etiology of AECOPD in Hong Kong.

Methods: Patients admitted to an acute hospital in Hong Kong with AECOPD were recruited prospectively from May 1, 2004, to April 30, 2005. Nasopharyngeal aspirate was collected and assessed by polymerase chain reaction (PCR) and viral culture. Spirometry was performed in the stable phase at 2 to 3 months after hospital discharge.

Results: There were 262 episodes of AECOPD among 196 patients (mean age, 75.7 +/- 7.7 years [+/- SD]; 160 men). Mean FEV(1) was 39.6 +/- 18.9% of predicted normal, and FEV(1)/FVC ratio was 58.0 +/- 15.2%. Fifty-eight episodes (22.1%) yielded positive viral PCR results. The viruses identified were influenza A (7.3%), coronavirus OC43 (4.6%), rhinovirus (3.1%), influenza B (2.7%), and respiratory syncytial virus (2.3%). The diagnostic yield of viral identification by PCR was 2.7 times higher than that based on conventional viral culture. The rates of identifying a positive viral etiology by PCR were similar among the subjects with FEV(1) >or= 50%, >or= 30 to 50%, and < 30% of predicted normal. Viral infection appeared to have no effect on subsequent readmissions or mortality rate over a study period of 1 year

Conclusion: Influenza A and two less-attended viruses, coronavirus OC43 and rhinovirus, were the common etiologic agents in patients hospitalized with AECOPD in Hong Kong. These should be considered in developing diagnostic and intervening strategies pertaining to AECOPD.

Citing Articles

The Convoluted Journey to Unveil the Respiratory Syncytial Virus in Chronic Obstructive Pulmonary Disease Exacerbations: Old Paths and New Traces.

Baraldi F, Contoli M, Papi A Am J Respir Crit Care Med. 2024; 210(8):967-969.

PMID: 38657157 PMC: 11531098. DOI: 10.1164/rccm.202403-0649ED.


Exploring the impact of OSA on short-term survival in patients with AECOPD admitted to the ICU.

Liu L, Chen Y, He G, Lin B, Zhu Z, Wei R PLoS One. 2024; 19(4):e0301646.

PMID: 38603665 PMC: 11008870. DOI: 10.1371/journal.pone.0301646.


Molecular Accounting and Profiling of Human Respiratory Microbial Communities: Toward Precision Medicine by Targeting the Respiratory Microbiome for Disease Diagnosis and Treatment.

Alsayed A, Abed A, Khader H, Al-Shdifat L, Hasoun L, Al-Rshaidat M Int J Mol Sci. 2023; 24(4).

PMID: 36835503 PMC: 9966333. DOI: 10.3390/ijms24044086.


COPD Exacerbation-Related Pathogens and Previous COPD Treatment.

Sim Y, Lee J, Lee E, Choi J, Lee C, An T J Clin Med. 2023; 12(1).

PMID: 36614912 PMC: 9821136. DOI: 10.3390/jcm12010111.


Therapeutic Approaches for Chronic Obstructive Pulmonary Disease (COPD) Exacerbations.

Rosenwasser Y, Berger I, Loewy Z Pathogens. 2022; 11(12).

PMID: 36558847 PMC: 9784349. DOI: 10.3390/pathogens11121513.


References
1.
Cameron R, de Wit D, Welsh T, Ferguson J, Grissell T, Rye P . Virus infection in exacerbations of chronic obstructive pulmonary disease requiring ventilation. Intensive Care Med. 2006; 32(7):1022-9. PMC: 7080063. DOI: 10.1007/s00134-006-0202-x. View

2.
Gern J, Galagan D, Jarjour N, DICK E, Busse W . Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med. 1997; 155(3):1159-61. DOI: 10.1164/ajrccm.155.3.9117003. View

3.
Rohde G, Borg I, Arinir U, Kronsbein J, Rausse R, Bauer T . Relevance of human metapneumovirus in exacerbations of COPD. Respir Res. 2005; 6:150. PMC: 1334186. DOI: 10.1186/1465-9921-6-150. View

4.
Vijgen L, Keyaerts E, Moes E, Maes P, Duson G, Van Ranst M . Development of one-step, real-time, quantitative reverse transcriptase PCR assays for absolute quantitation of human coronaviruses OC43 and 229E. J Clin Microbiol. 2005; 43(11):5452-6. PMC: 1287813. DOI: 10.1128/JCM.43.11.5452-5456.2005. View

5.
Seemungal T, Donaldson G, Paul E, Bestall J, Jeffries D, Wedzicha J . Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998; 157(5 Pt 1):1418-22. DOI: 10.1164/ajrccm.157.5.9709032. View